Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
about
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsOrchestration of H3K27 methylation: mechanisms and therapeutic implication.Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.
P2860
Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of the BRAF V60 ...... creatic neuroendocrine tumors.
@en
type
label
Identification of the BRAF V60 ...... creatic neuroendocrine tumors.
@en
prefLabel
Identification of the BRAF V60 ...... creatic neuroendocrine tumors.
@en
P2093
P2860
P356
P1433
P1476
Identification of the BRAF V60 ...... creatic neuroendocrine tumors.
@en
P2093
Charny Park
Gregory Lauwers
Hee Cheol Kim
Jeeyun Lee
Jin Seok Heo
Kyoung-Mee Kim
Sang Yun Ha
Seung Tae Kim
Young Suk Park
P2860
P304
P356
10.18632/ONCOTARGET.6602
P407
P577
2015-12-14T00:00:00Z